A precursor protein of 170 kDa is post-translationally modified via glycosylation and cleavage to give rise to a mature heterodimer [23]
[DOI] [PubMed] [Google Scholar] [120].Venable EB, Kelley MS, Raub R
Heres a general overview of the dosage: Initial Phase : Dosage : 600 to 1200 mg per week Frequency : 1 to 2 injections per week Duration : 1 to 3 months Maintenance Phase : Dosage : 600 to 1200 mg per month Frequency : 1 injection per month Duration : Ongoing, based on desired results Administration Methods: Intravenous (IV) Injection/Drip:
The fruits of these efforts will be in future years, given that medical product development, on average, can take a decade or longer, said Dr
That same economy, however, is why it is difficult in some experiments to separate a specific GHK signaling effect from the generic effect of simply making more copper available